Categories
News on Health & Science

Genes Hold Key to Living Longer Than 100

[amazon_link asins=’B01N7SZXH3,B01N7UW4P0,B01N9UEA1T,B01NBXDIQX,B01NCXV3UJ,B01MRG4QJO,B01MSHM8LZ,B01N3S0VAT,B01N9HZXBU’ template=’ProductCarousel’ store=’finmeacur-20′ marketplace=’US’ link_id=’d7ee85b1-0763-11e8-9a97-ab70c31db2c5′]

Exceptional longevity results from favourable genes much more than from a healthy lifestyle and environment, according to the first extensive genetic analysis of people who lived past the age of 100.

Researchers at Boston University have identified 150 genetic variants that, taken together, can predict exceptional longevity with 77 per cent accuracy.

The scientists compared the genomes of 1,055 centenarians with a similar number of control subjects, using DNA-scanning technology. They distilled the differences down to 150 life-extending changes, each affecting one chemical “letter” in the 3bn letters of the human genetic code.

These changes run right across the human genome. A few affect genes associated with age-related diseases, such as the ApoE and Alzheimer’s but many have unknown functions.

“Longevity is an extremely complex genetic trait involving many biological processes,” said Thomas Perls, co-author of the paper and director of the New England Centenarian Study. “We’re a long way from understanding them.”

The research confirmed that there could be no simple “elixir” to extend life, he added.

The scientists were surprised to find that, on the whole, the centenarians did not have fewer genetic variants known to trigger disease than the controls.

“What makes a difference is more the positive enriching effect of genetic variants that protect against disease than the absence of disease-associated variants,” said Dr Perls.

Although the details remain a mystery, what seems to happen as people age is that lifestyle and environment – such as healthy eating, exercising and avoiding smoking and obesity – are important in determining lifespan up to the 80s. After that, genes play an increasingly important role.

DNA rather than lifestyle is almost entirely responsible for generating “super-centenarians” who survive beyond 110. They make up one in 7m people in the industrial world.

Eighty-five per cent of centenarians and 90 per cent of super-centenarians are women. In spite of claims of people living to 140 or 150 in places from the Andes to the Caucasus, Jeanne Calment, who died in France in 1997 at the age of 122, remains the world’s oldest documented person.

Paola Sebastiani, professor of biostatistics at Boston University, said all data from the longevity study would be available without restrictions. “We have no financial interests in it and we are not planning to patent anything here,” she said.

Researchers will put up a web page this month where people can calculate their prospect of longevity. They also expect companies that sell genetic tests to consumers quickly to include a longevity assessment.

Source : Financial Times. July 1st.2010

Enhanced by Zemanta
Categories
Herbs & Plants

Allium drummondii

[amazon_link asins=’B00HME4N8M,B00KPSXUB8,B00I5S7LOM,B00K5WIM5I,B00QJDP8TK,B01CSVOBNA,B00K5WIUK0,B00DOJ8IA8,B01IW56WM4′ template=’ProductCarousel’ store=’finmeacur-20′ marketplace=’US’ link_id=’2ecc9b55-906f-11e7-a57e-ff18b066ffee’]

Botanical Name:Allium drummondii
Family : Alliaceae
Genus :Allium
Kingdom: Plantae
Order: Asparagales
Species:
A. drummondii

Synonyms :  Allium nuttallii – S.Watson.

Common Names: Prairie Onion, Drummond’s onion, Wild garlic .

Habitat :Native to  N. AmericaTexas to New Mexico, north to Nebraska. It grows on the  Ssndy or gravelly, often limestone soils on dry prairies and hills .

Description:
It is perennial plant. Bulb growing to 0.25m.  Drummond Onion is an upright to somewhat sprawling plant reaching 4-12 inches in height. Flowering stems and leaves form clusters of small bulbs, which are covered with fine mesh like netting. Flower color ranges from white to purple-red. This plant grows in calcareous or limestone soils of plains, prairies, and along hills and slopes. Drummond Onion is considered edible and good tasting. .

YOU MAY CLICK TO SEE THE PICTURE.………Allium Drummondii……..Drummond’s onion

It is hardy to zone 7. The lovely white flowers come into bloom April through May coming in a variety of colors ranging from white to pink. Seemingly a rather nice flowering species, Allium drummondii is quite an invasive fellow. Seemingly a rather nice flowering species, Allium drummondii is quite an invasive fellow. The flowers are hermaphrodite (have both male and female organs) and are pollinated by Bees, insects.
The plant prefers light (sandy) and medium (loamy) soils and requires well-drained soil. The plant prefers acid, neutral and basic (alkaline) soils. It cannot grow in the shade. It requires moist soil.

Cultivation :
Prefers a sunny position in a light well-drained soil. Succeeds in the rock garden, though in cold wet areas it is best grown in a bulb frame or cold greenhouse. The bulbs should be planted fairly deeply. Most members of this genus are intolerant of competition from other growing plants. The plants are much liked by grazing animals and have become rare or absent on pasture land. Grows well with most plants, especially roses, carrots, beet and chamomile, but it inhibits the growth of legumes. This plant is a bad companion for alfalfa, each species negatively affecting the other. Members of this genus are rarely if ever troubled by browsing deer.

Propagation:
Seed – sow spring in a cold frame. Prick out the seedlings into individual pots when they are large enough to handle – if you want to produce clumps more quickly then put three plants in each pot. Grow them on in the greenhouse for at least their first winter and plant them out into their permanent positions in spring once they are growing vigorously and are large enough. Division in spring. The plants divide successfully at any time in the growing season, pot up the divisions in a cold frame or greenhouse until they are growing well and then plant them out into their permanent positions.


Edible Uses:

Edible Parts: Flowers; Leaves; Root.

Bulb – raw or cooked. Used mainly as a condiment, the bulb is also eaten as a vegetable. The bulb is rather small, up to 25mm tall and 15mm in diameter. Leaves – raw or cooked. Flowers – raw. Used as a garnish on salads.

This species of Allium is gathered by Natives for its small edible bulbs. Drummond’s Onion contains a considerable amount of inulin, a non-reducing sugar that humans cannot digest. Because of this, these onions must be heated for a long period of time in order to convert the inulin into digestible sugars. Tribes of the Texas and New Mexico area used the onion as an addition to meat dishes, whereas some tribes in California often used it as a main dish.

Medicinal Uses:

Although no specific mention of medicinal uses has been seen for this species, members of this genus are in general very healthy additions to the diet. They contain sulphur compounds (which give them their onion flavour) and when added to the diet on a regular basis they help reduce blood cholesterol levels, act as a tonic to the digestive system and also tonify the circulatory system.

Other Uses
Repellent.

The juice of the plant is used as a moth repellent. The whole plant is said to repel insects and moles.
Known Hazards: Although no individual reports regarding this species have been seen, there have been cases of poisoning caused by the consumption, in large quantities and by some mammals, of certain members of this genus. Dogs seem to be particularly susceptible.

Disclaimer:The information presented herein is intended for educational purposes only. Individual results may vary, and before using any supplements, it is always advisable to consult with your own health care provider.


Resources:

http://www.pfaf.org/database/plants.php?Allium+drummondii
http://en.wikipedia.org/wiki/Allium_drummondii
http://uvalde.tamu.edu/herbarium/aldr.htm

Enhanced by Zemanta
Categories
News on Health & Science

Vitamin C Intake May Lower Risk of Gout in Men

[amazon_link asins=’B001GAOGC6,B003FW4UME’ template=’ProductCarousel’ store=’finmeacur-20′ marketplace=’US’ link_id=’eb35d7f8-0797-11e7-982b-df31a5059ce0′]

[amazon_link asins=’B00TP54IFO,B00T40H4RO’ template=’ProductCarousel’ store=’finmeacur-20′ marketplace=’US’ link_id=’02e9ce85-0798-11e7-b6ab-158e65f0039a’]

 Men with a higher intake of vitamin C appear less likely to develop gout, a painful type of arthritis, according to a study.
……………….CLICK & SEE

Gout is the most common type of inflammatory arthritis in men… The identification of risk factors for gout… is an important first step in the prevention and management of this common and excruciatingly painful condition,” wrote the study’s authors.

Hyon K Choi, then of University of British Columbia, Vancouver, and now of Boston University School of Medicine, and colleagues examined the relationship between vitamin C intake and gout in 46,994 men between 1986 and 2006.

Every four years, the men completed a dietary questionnaire, and their vitamin C intake through food and supplements was computed. Every two years, participants reported whether they had been diagnosed with or developed symptoms of gout.

During 20-year follow-up, 1,317 men developed gout. Compared with men who had a vitamin C intake of less than 250mg per day, the relative risk of gout was 17% lower for those with a daily intake of 500 to 999 mg, 34% lower for those with an intake of 1,000 to 1,499mg per day and 45% lower for those with an intake of 1,500mg per day or higher.

Vitamin C may affect re-absorption of uric acid by the kidneys, increase the speed at which the kidneys work or protect against inflammation, all of which may reduce gout risk, a Boston University statement quoted the authors as saying.

Sources:These findings were published in the Archives of Internal Medicine.

Categories
Featured News on Health & Science

The Unfolding Mystery of Scleroderma

[amazon_link asins=’1590770234,B013BAX1W4,1461490278,B00U7TCV7O,B01G49GPCC,B0194AORKA,1569244391,1591099803,B001FB6E6W’ template=’ProductCarousel’ store=’finmeacur-20′ marketplace=’US’ link_id=’1a25d7b4-1766-11e7-b3e0-f96d57182cc3′]

Scleroderma, an autoimmune disease, tends to afflict middle-age women and can affect many parts of the body, inside and out.

CLICK & SEE

Lung disease, the biggest killer of scleroderma patients, is the main focus of research today..

Doctors have a growing arsenal of proven and potential treatments, some of which are risky and the subjects of current research, including stem cell transplants and powerful but toxic cancer drugs.

Like many autoimmune ailments, scleroderma remains a great unknown. Despite decades of research, the cause of this rare and complicated disease has yet to be discovered. But the good news is that doctors have a pretty clear understanding of how scleroderma progresses — a natural history, they call it — and are better than ever at extending and easing their patients’ lives.

“Lots of patients and lots of doctors used to consider it a ‘black box’ disease, a complete mystery, with little that could be done,” said Dr. Philip J. Clements of the University of California, Los Angeles, who is a scleroderma specialist. “Now there’s a body of evidence that tells us what to watch out for, and when.”

Experts now know, for example, that the gradual hardening of tissues and blood vessels that is a hallmark of scleroderma usually starts on the hands and face, with skin thickening, pitted scars and cool, pale fingertips among the earliest symptoms. Damage can then progress inward to internal organs, though the course varies widely from patient to patient. Of the 10,000 cases diagnosed among Americans each year, mainly women, a small subset will die quickly. But many others are able to manage their condition with a variety of treatments and have normal life expectancies.

Doctors also now know that if a patient’s internal organs are going to be affected as well as the skin, that is likely to happen in the first four or five years of the disease. So early diagnosis and close monitoring of the heart, lungs and kidneys are vitally important.

They have also learned that steroids, once viewed as a cure-all for immune disorders, can worsen the effects of scleroderma, especially in the kidneys, and should be used with caution.

“Learning which drugs to avoid was itself a big step,” said Dr. John Varga, the Gallagher Professor of Medicine at Northwestern University and chairman of the Medical Advisory Board for the Scleroderma Foundation, a nonprofit group that sponsors research and support for patients and families.

Kidney disease used to cause 90 percent of scleroderma-related deaths until the advent of a class of blood pressure drugs called angiotensin-converting enzyme, or ACE, inhibitors in the 1980s. ACE inhibitors prevent kidney damage by slowing down the chemicals that cause the muscles surrounding blood vessels to contract. Complications in the kidneys now account for only 14 percent of scleroderma deaths, Dr. Steen said.

The lungs are still a challenge. About 80 percent of scleroderma patients develop some form of lung problem — either pulmonary hypertension, due to hardening of the veins and arteries in the lung, or pulmonary fibrosis, in which the lung tissue becomes inflamed and then thickened with scarring. Some patients develop both. Either way, breathing becomes more difficult as the lungs become less pliable.

“If you die of a scleroderma-related problem, half of those deaths are from lung disease,” said Dr. Virginia Steen, a professor at Georgetown University and director of the Rheumatology Fellowship Program there. She wrote a seminal 2007 article that documented the shift from kidney disease to pulmonary disease as the biggest cause of death among scleroderma patients.

One successful remedy called Revatio, routinely prescribed since 2005, came from an unexpected source: Viagra. Repackaged from a little blue diamond to a round white tablet and renamed for marketing, dosage and insurance purposes, the drug works by relaxing the blood vessels and improving blood flow, whether for erectile or lung dysfunction.

“No one could understand why all these women were taking it four times a day,” said Frannie Waldron, chief executive of the Scleroderma Foundation.

Doctors also have a growing arsenal of experimental treatments and potential cures, some of which are risky.

Among them is cyclophosphamide, or Cytoxan, a powerful but highly toxic cancer drug that acts on the immune system. The drug decreases the inflammation that causes pulmonary fibrosis and has been used on scleroderma patients for the last 10 years.

But cytoxan has dangerous side effects, including an increased risk of bladder cancer, and usually is not given for more than a year. Moreover, the fibrosis seems to start again once drug treatments stop. Several studies involving the medication are under way, as well as efforts to find alternative treatments, many of them sponsored by drug companies.

Another big push involves stem cell transplant, an extremely risky process in which doctors try to reset the patient’s immune system and bypass the glitch that causes scleroderma. The procedure is the subject of a National Institutes of Health study called the SCOT trial, for Scleroderma: Cyclophosphamides or Transplantation?

Similar to a bone marrow transplant, doctors first draw the patient’s blood and extract the stem cells, the highly malleable building blocks that are thought to be free of the seeds of scleroderma. The patient is then subjected to high doses of radiation or chemotherapy with Cytoxan to kill the bone marrow. The last step is to reinfuse the stem cells, in the hopes that they replicate themselves in a healthy form free of disease.

The study will compare the benefits of the stem cell transplant with giving patients just monthly doses, but high ones, of Cytoxan. Preliminary results have been promising, several experts said.

“You’d think you’d have trouble recruiting for this,” said Dr. Arthur C. Theodore of Boston University, one of the investigators in the project. “But scleroderma patients are desperate.”

Sources
: The New York Times

Reblog this post [with Zemanta]
Categories
Featured

3 Myths About Running and Your Health

[amazon_link asins=’B06XFVK2T6,B06XP21JV6,B06Y59CZ94,B01J1RY0AS,B075JC5YYM,B07234VH12,B076YDJBRV,B01M5L5AHA,B075WRF5NF’ template=’ProductCarousel’ store=’finmeacur-20′ marketplace=’US’ link_id=’b3ede441-096c-11e8-bdb6-d9a3ac146d0d’]

Every person who takes up running has been confronted by a “helpful” critic who is more than happy to reel off the reasons running will ruin your life. Here’s a look at three questionable claims about running and health:

1. Running will give you a heart attack or other heart problems. It is true that exercise temporarily raises the odds of a heart attack while you’re mid-workout, but doing it consistently reduces that risk over the long haul, leading to a net benefit. Going for a run most days of the week is doing far more good than bad for your heart.

2. Running will ruin your bones and joints. A study in the American Journal of Preventive Medicine found no evidence of accelerated rates of osteoarthritis among long-distance runners. Weight-bearing exercise like running helps stave off osteoporosis by maintaining bone mineral density.

3. Running will kill you before your time. According to a study in the Archives of Internal Medicine, running and other vigorous exercise in middle age is associated with a longer life. Not only that, it will make your later years more pleasant by reducing disability.

Sources:
U.S. News & World Report August 13, 2008
American Journal of Preventive Medicine August 2008; 35(2):133-8
Archives of Internal Medicine August 11, 2008; 168(15):1638-46

Reblog this post [with Zemanta]
css.php